treating hiv with azidothymidine (azt)
DESCRIPTION
Treating HIV with Azidothymidine (AZT). A Design by Jeanine Nasser. Background Information. HIV (Human Immunodeficiency Virus): an infection that weakens the human body’s immune system by destroying important cells that fight disease and infection (T-helper cells) - PowerPoint PPT PresentationTRANSCRIPT
![Page 1: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/1.jpg)
Treating HIV with Azidothymidine (AZT)
A Design by Jeanine Nasser
![Page 2: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/2.jpg)
HIV (Human Immunodeficiency Virus): an infection that weakens the human body’s immune system by destroying important cells that fight disease and infection (T-helper cells)
AIDS (Acquired Immunodeficiency Syndrome): the most advanced stage of the HIV virus; a complex illness with a wide range of complications and symptoms
Background Information
![Page 3: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/3.jpg)
More than 25 million people are now living with HIV
In 2013, an estimated 2.1 million people were affected with HIV, 1.5 million of whom were from Sub-Sahara Africa
Everyday more than 5,700 people contract HIV
Around 12.9 million people living with HIV (37% of the total) had access to antiretroviral therapy
(Stats from amtAR-2013)
Statistics
![Page 4: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/4.jpg)
At the moment, there is no preventive vaccine available and treatment is unaffordable for people who need it
Treatment is the most feasible approach to reverse and ultimately halt the HIV epidemic
HIV is a preventable disease; effective HIV prevention interventions have been proven to reduce HIV transmission
PurposeWhy is HIV Prevention
Important?
![Page 5: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/5.jpg)
Although there is no cure for HIV, physicians prescribe combinations of different medications (“cocktails”) that indirectly affect the HIV virus by targeting and strengthening the body’s immune system However, there are a few disadvantages to
taking these cocktails: They’re expensive They must be taken throughout one’s lifetime They’re not easily accessible They can cause some discomforting side effects
Treatment
![Page 6: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/6.jpg)
1. Binding (Attachment): HIV binds to the receptors on the surface of a CD4 (T-helper) cell
The HIV Life Cycle
![Page 7: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/7.jpg)
2. Fusion: The HIV envelope and the T-helper cell membrane fuse, which allows the HIV to inject its viral core containing RNA
The HIV Life Cycle
![Page 8: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/8.jpg)
3. Reverse Transcription: Once inside the T-helper cell, HIV releases reverse transcriptase. HIV uses reverse transcriptase to convert its genetic material (HIV RNA) into HIV DNA
The conversion of HIV RNA to DNA is necessary so that the HIV can enter the nucleus of the T-helper cell and combine with the cell’s DNA
The HIV Life Cycle
![Page 9: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/9.jpg)
4. Integration: HIV produces integrase (enzyme), which allows the HIV DNA to enter the T-helper cell nucleus. Once inside the cell nucleus, the HIV DNA is joined with the T-helper cell DNA
The HIV Life Cycle
![Page 10: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/10.jpg)
5. Transcription and Translation: Once HIV is integrated into the t-helper cell DNA, the virus begins to use the protein-making mechanisms of the t-helper cell to create long chains of HIV proteins, which are the building blocks for making more HIV
The HIV Life Cycle
![Page 11: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/11.jpg)
6. Assembly: Protease (an HIV enzyme) cuts up the long chains of HIV proteins. The smaller HIV proteins combine with HIV RNA to form a new virus
The HIV Life Cycle
![Page 12: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/12.jpg)
7. Budding: Newly made HIV pushes out from the T-helper cell
The HIV Life Cycle
![Page 13: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/13.jpg)
To disturb the reverse transcription phase of the HIV
life cycle to prevent the formation of viral DNA
Objective of My Design
![Page 14: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/14.jpg)
What is AZT?AZT: Azidothymidine
How does it inhibit reverse transcription?
• AZT is a nucleoside reverse transcription inhibitor (NRTI), meaning that when it is incorporated into a DNA template during reverse transcription, it is confused for one of the original nucleotides in DNA (in this case, thymidine)
• Because AZT lacks a 3’ hydroxyl group, the DNA chain cannot be extended, making AZT a chain terminator
What makes it an effective reverse transcription inhibitor?
• If the AZT is released, it can selectively inhibit the HIV’s reverse transcriptase, as reverse transcription is necessary for production of HIV’s double-stranded DNA to subsequently be integrated into the genetic material of the infected cell.
![Page 15: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/15.jpg)
Mechanism of Design1. Receptors on cell membrane activate promoter
of first device in indication of presence of gp120 protein
2. Gene injected with AZT releases AZT3. To indicate that AZT released, a second
promoter is activated4. If AZT is present, glowing fluorescent protein
(GFP) is released Presence of gp120 Release of AZT GFP Glows
1 1 1
0 0 0
![Page 16: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/16.jpg)
![Page 17: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/17.jpg)
Advantages & Disadvantages
Advantages
1. Easily accessible
2. Affordable
3. Permanent effect
Disadvantages
1. Potential overdose of AZT, as
there is no negative feedback
2. Some patients may not
respond to the vaccine
![Page 18: Treating HIV with Azidothymidine (AZT)](https://reader030.vdocuments.net/reader030/viewer/2022020718/56812c50550346895d90d818/html5/thumbnails/18.jpg)
Testing
The effectiveness of the system would be tested
by first taking a blood sample from a patient with
the HIV virus. The bacteria is then inserted into
the blood sample. Once the bacteria is in the
presence of the HIV virus, it can then be
determined whether the system is functioning
properly by observing the change in the color of
the system (i.e., if it glows green or of it does
not).